Ajuste direto para aquisição de A53311- Acalabrutinib [100 mg; cáp/comp] e T1820- Ticagrelor [60 mg; comp]

ID 11146884 · Portal BASE
Price
Base Price
€271,602 .00
Effective Price
€42,428 .00 -84.4%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Lisboa, Lisboa
Bidder Count
1
Winner
ASTRAZENECA - PRODUTOS FARMACÊUTICOS LDA
NIF 502942240
Company
Competition
1 bidder recorded
ASTRAZENECA - PRODUTOS FARMACÊUTICOS LDA
NIF 502942240
Dates
Publication
10 Jan 2025
Celebration
09 Jan 2025
Contracting Entity
Centro Hospitalar Universitário de Lisboa Norte, EPE
NIF 508481287
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 30 · LOW RISK
A6 · Low Competition
A6_LOW_COMPETITION
MEDIUM
Rule
a6_single_bidder
Bidder count
1
Detected 2026-04-17
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
LOW
Base price
271602.0
Total effective price
42428.0
Ratio
0.1562
Direction
reduction
Rule
A9 price reduction: ratio 0.1562 outside [0.5, 1.5]
Detected 2026-03-06